A series of studies have indicated that SWI/SNF mutations, particularly SMARCA4 mutations, are often accompanied by mutations in TP53, KRAS, KEAP1, STK11 and other genes in lung cancer. The gene discussed is TP53; the disease is lung carcinoma.